Bundle Sales Theronomic Flora Reshape Akkermansia Buy 3 Packs Get Free Gift

Product Overview

Theronomic Flora Reshape Akkermansia is formulated around Akkermansia muciniphila MucT™ — a clinically researched mucus-layer bacterium that constitutes a key species in a healthy human gut microbiome. Published studies, including those in Nature Medicine and Cell Metabolism, have linked higher relative abundance of Akkermansia muciniphila to improved metabolic markers, reduced intestinal permeability ("leaky gut"), and more favourable outcomes in weight management interventions. The pasteurised MucT™ form used in this product ensures stability and standardised dose delivery at 30 billion cells per capsule.

The Tribiotic™ platform integrates prebiotic, probiotic, and postbiotic components in a single-capsule format. Livaux® Gold Kiwifruit Powder is a clinically validated prebiotic (Actinidia chinensis) that preferentially increases Bifidobacterium populations; Solnul™ Resistant Starch provides fermentable substrate for short-chain fatty acid (SCFA) production, supporting colonocyte health and mucosal immune regulation. Lactobacillus plantarum IMC510 contributes additional epithelial barrier support and immunomodulatory activity. This three-component Tribiotic™ design is patented by Theronomic Pty Ltd and represents Australia's first integrated approach of this kind for gut microbiome restoration.

Specifications

Clinical Applications

• Gut microbiome restoration: Akkermansia muciniphila supplementation is used by functional medicine and gastroenterology practitioners to restore mucosal layer integrity in patients with reduced microbial diversity associated with antibiotic use, dietary imbalance, or metabolic syndrome.
• Metabolic health support: Published clinical data (Nature Medicine, 2019) demonstrates that pasteurised Akkermansia muciniphila supplementation over 3 months significantly improved insulin sensitivity, reduced plasma lipopolysaccharide levels, and modestly decreased body weight and fat mass in overweight adults with metabolic syndrome.
• Intestinal permeability management: The prebiotic–probiotic–postbiotic Tribiotic™ combination supports tight junction protein expression (ZO-1, occludin) in intestinal epithelial cells, relevant to patients with functional gastrointestinal disorders and systemic inflammatory conditions linked to intestinal hyperpermeability.
• Post-antibiotic microbiome recovery: The multi-strain probiotic matrix combined with Livaux® kiwifruit prebiotic is used in Singapore integrative medicine practices to support microbiome diversity recovery following broad-spectrum antibiotic therapy.
• Preventive gut health maintenance: The 90-day bundle format supports the minimum intervention duration required to observe statistically significant microbiome compositional shifts in published probiotic clinical trials.

Frequently Asked Questions

Q: What is the evidence base for Akkermansia muciniphila as a probiotic?
A: Akkermansia muciniphila is one of the most extensively researched next-generation probiotic strains. A landmark 2019 study in Nature Medicine (Plovier et al. and Depommier et al.) demonstrated that pasteurised A. muciniphila supplementation in overweight adults with metabolic syndrome improved insulin sensitivity, reduced plasma lipopolysaccharides, and improved metabolic markers compared to placebo over 12 weeks. The TGA-listed Flora Reshape Akkermansia uses the pasteurised MucT™ form shown to be stable and clinically effective.

Q: Why is the Akkermansia in this product pasteurised rather than live?
A: Research has shown that pasteurised (heat-inactivated) Akkermansia muciniphila retains its bioactivity and clinical efficacy. The pasteurised form is more stable at ambient temperatures, does not require refrigeration for the same shelf life as live cultures, and has been the form used in human clinical trials demonstrating metabolic health benefits. The MucT™ certification ensures standardised dose verification in each capsule.

Q: Is this product suitable for use alongside proton pump inhibitors (PPIs) or other GI medications?
A: Probiotic supplements classified as food-grade health products generally do not interact pharmacokinetically with PPIs, H2 blockers, or antacids. However, the timing of probiotic administration should be separated from antibiotic doses by at least 2 hours. Patients with immune-compromising conditions, inflammatory bowel disease (IBD), or those on immunosuppressant therapy should consult their gastroenterologist before commencing probiotic supplementation.

Q: How long does it take to see clinical changes in gut microbiome composition?
A: Probiotic intervention studies using 16S rRNA sequencing typically detect measurable shifts in gut microbiome composition within 4–8 weeks of consistent supplementation. Clinically meaningful outcomes, such as changes in metabolic biomarkers or bowel function, are generally observed after 8–12 weeks. The three-pack bundle provides 90 capsules, supporting a full 90-day protocol at the recommended 1-capsule daily dose.

Q: Can I purchase this product for clinic use or B2B supply in Singapore?
A: EMIS Asia provides B2B procurement for Singapore healthcare facilities including GP clinics, integrative medicine centres, functional nutrition practices, and hospital pharmacy departments. TGA documentation (ARTG 491665), HSA notification certificates, and product dossiers are available upon request for institutional procurement and formulary approval processes.